Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer - Bertin Instruments

Scientific publications

Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer

Aure´ lie Courtin1,3, Frances M. Richards1,3*, Tashinga E. Bapiro1,3, Jo L. Bramhall1,3, Albrecht Neesse2,3¤a,Natalie Cook2,3, Ben-Fillippo Krippendorff1,3¤b, David A. Tuveson2,3¤c, Duncan I. Jodrell1,3
Sources: 1 Pharmacology, and Drug Development Group, Cancer research, UK Cambridge Research Institute, Cambridge, United Kingdom, 2 Tumour Modelling and Experimental Medicine Group, Cancer research, UK Cambridge Research Institute, Cambridge, United Kingdom, 3 University of Cambridge Department of Oncology, Cambridge, United Kingdom, Cambridge, United Kingdom

Sample name

Animal tissues (mice liver)

Kits

MK28-R_2mL

ANY QUESTIONS? CONTACT AN EXPERT

Please fill in this form if you wish to contact our sales team or receive further information.

My Account
Forgot password ?

Add a question !

Add a question